Playback speed
10 seconds
ESMO 2022: Should All Advanced Ovarian Cancer Patients Receive a PARPi in 1L Therapy?
By
ESMO 2022 Conference Coverage
FEATURING
David Tan
By
ESMO 2022 Conference Coverage
FEATURING
David Tan
782 views
September 19, 2022
Login to view comments.
Click here to Login